0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Month in Archives of Dermatology |

This Month in Archives of Dermatology FREE

Arch Dermatol. 2012;148(4):421. doi:10.1001/archdermatol.2011.524.
Text Size: A A A
Published online

A SYSTEMATIC REVIEW OF TREATMENTS FOR HIDRADENITIS SUPPURATIVA

Hidradenitis suppurativa (HS) is a chronic, inflammatory, debilitating follicular disease that manifests with deep inflamed nodules in the apocrine gland–bearing areas of the body. In this comprehensive review of research studies on HS treatment in the last 20 years, Rambhatla et al demonstrate that most therapies used to treat HS were supported by limited or weak scientific evidence owing to a paucity of randomized controlled studies. Effective treatments include a clindamycin-rifampin combination, a course of infliximab, monthly Nd:YAG laser sessions, and surgical excision and primary closure with a gentamicin sulfate–collagen sponge.

See Article

A CROSS-SECTIONAL STUDY EXAMINING THE CORRELATION BETWEEN SUNLESS TANNING PRODUCT USE AND TANNING BELIEFS AND BEHAVIORS

Despite the growing popularity of sunless tanning products (STPs), their effect on tanning behaviors has not been fully explored. Some studies support STP use as an acceptable substitute for UV radiation (UVR) tanning methods, but others raise concerns that STPs encourage intentional UVR exposure. In this cross-sectional survey study, Sahn et al demonstrate that the desire for tanned skin remains strong and that in some women, STP use is associated with decreased UVR tanning frequency. Improvements in the appearance of STP-induced tans may allow wider public acceptance and a further decrease in UVR tanning practices.

See Article

MAGGOT THERAPY FOR WOUND DEBRIDEMENT

Wound-bed preparation with debridement not only helps remove damaged tissue and biofilms and restore normal bacterial flora, it also improves growth factors and senescent cell activities. In this randomized, controlled, prospective clinical trial, Opletalová et al demonstrate no significant difference between maggot debridement therapy (MDT) and conventional therapy at day 15. However, debridement by MDT was significantly faster in the first week of therapy, reaching the same level as the control group at day 15. This may prove useful in wounds needing fast debridement, such as in preparation for skin grafting. An additional MDT advantage is the lack of operator dependency.

See Article

LOW BLOOD CONCENTRATION OF HYDROXYCHLOROQUINE IN PATIENTS WITH REFRACTORY CUTANEOUS LUPUS ERYTHEMATOSUS

Antimalarial agents, including hydroxychloroquine (HCQ), are considered first-line systemic treatment for cutaneous lupus erythematosus (CLE). Prescribed HCQ doses theoretically depend on patient weight, but a standard dose of 400 mg/d is often prescribed regardless of patient height and weight. In this prospective multicenter study, Francès et al demonstrate that median blood HCQ concentration was significantly higher in patients with complete remission. Ten percent of patients had very low blood HCQ concentration and may be considered nonadherent. These data indicate that monitoring blood HCQ concentration might be very useful in the management of patients with CLE being treated with HCQ.

See Article

COMPARATIVE EFFECTIVENESS OF COMMONLY USED SYSTEMIC TREATMENTS OR PHOTOTHERAPY FOR MODERATE TO SEVERE PLAQUE PSORIASIS IN THE CLINICAL PRACTICE SETTING

Psoriasis is a common, chronic, inflammatory disease of the skin and joints. Use of traditional oral systemic therapies for moderate to severe psoriasis such as methotrexate, acitretin, and cyclosporine may be limited by patient intolerance or organ-specific toxic effects. Several new biologic drugs have been approved for the treatment of moderate to severe psoriasis, but they are associated with high costs, diminished efficacy during long-term treatment, and risks of rare but serious adverse effects. In this cross-sectional study, Gelfand et al demonstrate that patients taking adalimumab, etanercept, and ustekinumab were more likely to have clear or almost clear skin compared with those taking methotrexate. Patients receiving phototherapy showed no difference compared with methotrexate.

See Article

First Page Preview

View Large
First page PDF preview

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

431 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs